Arun Jaitley admitted to AIIMS, to undergo surgery today

NEW DELHI: Finance Minister Arun Jaitley was on Friday admitted to AIIMS and is scheduled to undergo a kidney transplant operation today, sources said.

Jaitley, 65, has been suffering from a kidney ailment and skipped office since Monday. He has not even taken oath of office after being re-elected to the Rajya Sabha.

Sources said the minister, who was confined to a ‘controlled environment’ at home, was shifted to the All India Institute of Medical Sciences (AIIMS) this evening.

A kidney transplant operation is scheduled for today, they said, adding all formalities for a donor kidney have been completed.

The minister, who cancelled his scheduled visit to London for the 10th India-UK Economic and Financial Dialogue next week, had confirmed his illness in a tweet on Thursday.

“I am being treated for kidney related problems & certain infections that I have contracted,” he had tweeted.

Jaitley, however, had not elaborated on the ailment, but said he was “currently working from controlled environment at home. The future course of my treatment would be determined by the doctors treating me.”

He is likely to be operated by nephrologist Dr Sandeep Guleria from Apollo hospital, also brother of AIIMS Director Randeep Guleria, who is a family friend of Jaitley.

Jaitley had in September 2014 undergone a bariatric surgery to treat weight gain that he suffered because of a long-standing diabetic condition. That surgery was first performed at Max Hospital, but he had to be later shifted to AIIMS because of complications.

He had a heart surgery several years ago.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states